Pharmaceuticals by operating margin
Operating income as a share of revenue for the latest fiscal year: what the business keeps of each dollar of sales before interest and tax. Banks, insurers and other companies that report no operating income are not ranked.
Royalty Pharma leads the 43 pharmaceuticals ranked by operating margin, at 65.6%, ahead of PTC Therapeutics (50.1%) and United Therapeutics (46.9%). Figures as of 18 Nov 2026, 13:57 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 43
- First
- Royalty Pharma65.6%
- Median
- 12.5%
- Combined market value
- AED 18.94T
- Countries
- 10
- Not ranked
- 18no operating margin on file
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Operating margin ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Royalty PharmaRPRX · Health Care | 65.6% | AED 145B | AED 252.24 | 0.23% up | 78% up | ||
| 2 | PTC TherapeuticsPTCT · Health Care | 50.1% | AED 18.5B | AED 221.68 | 1.00% down | 20% down | ||
| 3 | United TherapeuticsUTHR · Health Care | 46.9% | AED 91.4B | AED 2,145.22 | 0.64% down | 23% up | ||
| 4 | Novo NordiskNVO · Health Care | 41.3% | AED 658.8B | AED 149.48 | 2.16% down | 17% down | ||
| 5 | Vertex PharmaceuticalsVRTX · Health Care | 34.8% | AED 497.4B | AED 1,961.96 | 0.67% down | 27% up | ||
| 6 | NovartisNVS · Health Care | 32.4% | AED 1.1T | AED 584.44 | 0.67% down | 25% up | ||
| 7 | GenmabGMAB · Health Care | 28.6% | AED 117.7B | AED 190.83 | 0.76% up | 70% up | ||
| 8 | Regeneron PharmaceuticalsREGN · Health Care | 24.9% | AED 363.9B | AED 3,517.57 | 0.56% up | 36% up | ||
| 9 | AbbVieABBV · Health Care | 24.6% | AED 1.9T | AED 1,075.44 | 0.59% down | 26% up | ||
| 10 | GSKGSK · Health Care | 24.3% | AED 362.5B | AED 180.84 | 2.32% down | 6% up | ||
| 11 | AstraZenecaAZN · Health Care | 23.4% | AED 1.04T | AED 669.42 | 0.95% down | 2% up | ||
| 12 | TG TherapeuticsTGTX · Health Care | 20.0% | AED 34.8B | AED 230.32 | 0.08% down | 107% up | ||
| 13 | Abbott LaboratoriesABT · Health Care | 18.2% | AED 666.1B | AED 384.57 | 2.55% down | 17% down | ||
| 14 | AlkermesALKS · Health Care | 17.2% | AED 28.1B | AED 166.92 | 2.32% down | 58% up | ||
| 15 | GrifolsGRFS · Health Care | 16.5% | AED 21.6B | AED 31.70 | 1.15% down | 1% up | ||
| 16 | Ligand PharmaceuticalsLGND · Health Care | 15.3% | AED 21.6B | AED 1,079.08 | 2.62% down | 43% up | ||
| 17 | Dr. Reddy's LaboratoriesRDY · Health Care | 15.0% | AED 45.3B | AED 54.32 | 0.61% up | 5% up | ||
| 18 | SanofiSNY · Health Care | 14.5% | AED 419.2B | AED 174.56 | 1.78% down | 4% down | ||
| 19 | Alnylam PharmaceuticalsALNY · Health Care | 13.5% | AED 77B | AED 574.78 | 2.02% down | 66% down | ||
| 20 | Amneal PharmaceuticalsAMRX · Health Care | 13.1% | AED 27B | AED 77.57 | 0.52% down | 83% up | ||
| 21 | BioMarin PharmaceuticalBMRN · Health Care | 12.7% | AED 41.6B | AED 214.89 | 0.90% up | 11% up | ||
| 22 | Teva Pharmaceutical IndustriesTEVA · Health Care | 12.5% | AED 182.6B | AED 156.53 | 0.12% up | 74% up | ||
| 23 | Arrowhead PharmaceuticalsARWR · Health Care | 11.9% | AED 22.3B | AED 157.89 | 2.76% down | 10% up | ||
| 24 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 11.4% | AED 27.4B | AED 349.31 | 0.93% up | 126% up | ||
| 25 | BeOne MedicinesONC · Health Care | 8.37% | AED 173.4B | AED 1,517.78 | 0.48% up | 17% up | ||
| 26 | Corcept TherapeuticsCORT · Health Care | 5.88% | AED 28.2B | AED 257.35 | 1.23% up | 8% down | ||
| 27 | Takeda PharmaceuticalTAK · Health Care | 0.14% | AED 253.9B | AED 79.48 | 0.23% up | 54% up | ||
| 28 | Mirum PharmaceuticalsMIRM · Health Care | -4.25% | AED 22B | AED 337.70 | 0.40% up | 31% up | ||
| 29 | Jazz PharmaceuticalsJAZZ · Health Care | -10.1% | AED 56.7B | AED 884.06 | 0.39% up | 37% up | ||
| 30 | Travere TherapeuticsTVTX · Health Care | -12.8% | AED 18B | AED 187.67 | 2.82% up | 44% up | ||
| 31 | Legend BiotechLEGN · Health Care | -13.3% | AED 11.5B | AED 59.17 | 0.75% up | 42% down | ||
| 32 | ViatrisVTRS · Health Care | -18.6% | AED 86.1B | AED 75.11 | 1.40% down | 96% up | ||
| 33 | Ascendis PharmaASND · Health Care | -18.9% | AED 65.3B | AED 996.00 | 0.20% down | 28% up | ||
| 34 | Axsome TherapeuticsAXSM · Health Care | -26.1% | AED 26.3B | AED 499.30 | 0.77% down | 7% down | ||
| 35 | Madrigal PharmaceuticalsMDGL · Health Care | -31.3% | AED 36B | AED 1,549.84 | 0.46% down | 24% down | ||
| 36 | Ionis PharmaceuticalsIONS · Health Care | -40.4% | AED 16.5B | AED 99.02 | 3.75% down | 64% down | ||
| 37 | Rhythm PharmaceuticalsRYTM · Health Care | -101% | AED 29.7B | AED 428.27 | 8.49% up | 13% up | ||
| 38 | BridgeBio PharmaBBIO · Health Care | -104% | AED 54.9B | AED 282.06 | 0.72% down | 17% up | ||
| 39 | InsmedINSM · Health Care | -206% | AED 98.2B | AED 447.56 | 0.83% down | 40% down | ||
| 40 | Protagonist TherapeuticsPTGX · Health Care | -344% | AED 29.9B | AED 457.88 | 0.13% down | 46% up | ||
| 41 | CytokineticsCYTK · Health Care | -695% | AED 26.4B | AED 189.69 | 2.86% down | 20% down | ||
| 42 | Roivant SciencesROIV · Health Care | -6236% | AED 103B | AED 142.17 | 0.26% up | 90% up | ||
| 43 | Dianthus TherapeuticsDNTH · Health Care | -8739% | AED 18B | AED 319.45 | 2.87% down | 113% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Operating margin is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Banks and insurers report no operating income and are not ranked on it. Sums are converted from US dollars at today's exchange rate (1 USD = 3.6727 AED). 18 companies have no operating margin on file and are not ranked here.
Questions and answers
Which pharmaceuticals rank first by operating margin?
Royalty Pharma (65.6%), PTC Therapeutics (50.1%) and United Therapeutics (46.9%) are the top three of the 43 pharmaceuticals ranked by operating margin as of 18 Nov 2026, 13:57 UTC.
How many pharmaceuticals are in this ranking?
43 are ranked by operating margin. 18 more have no operating margin on file and are left out rather than ranked at zero.
What are these pharmaceuticals worth together?
The 43 pharmaceuticals ranked by operating margin have a combined market value of AED 18.94T as of 18 Nov 2026, 13:57 UTC.
What does ranking by operating margin measure?
Operating income as a share of revenue for the latest fiscal year: what the business keeps of each dollar of sales before interest and tax. Banks, insurers and other companies that report no operating income are not ranked.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Pharmaceuticals by operating margin”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=operating-margin
Underlying data: Yahoo Finance; SEC EDGAR.